EventInvest
Sign in
Krebs Biochemicals & Industries LimitedKREBSBIO

Krebs Biochemicals & Industries Limited: Merger

Krebs Biochemicals & Industries Limited is merging into Ipca Laboratories Limited; 7 shares of Ipca Laboratories Limited for every 200 shares of Krebs Biochemi…

Next dateNo date has been stated yet.Stage 2 of 7: Exchange no-objection

Terms

Each figure links to its source
Swap ratio
7 shares of Ipca Laboratories Limited for every 200 shares of Krebs Biochemicals & Industries Limited
Appointed date
Not known: Not yet stated in a filing
Record date
Not known: Not yet stated in a filing
Effective date
Not known: Not yet stated in a filing
Merging company
Krebs Biochemicals & Industries Limited
Surviving company
Ipca Laboratories Limited
Stock exchanges (observation letter): received 2 Nov 2026Shareholders and creditors: pendingNational Company Law Tribunal: pending

Timeline

12 steps
  1. Board approval26 Jun 2026
  2. Draft scheme filed with the exchanges6 Jul 2026
  3. Exchange observation letter2 Nov 2026

9 more steps, each with its date and filing. Free with a Google sign-in.

Sign in with Google

Source documents

12 filings

12 filings from the exchanges and SEBI, with links. Free with a Google sign-in.

Sign in with Google

What this means for a shareholder

In a merger by scheme of arrangement, shareholders of the merging company receive shares of the surviving company at a fixed swap ratio. The scheme needs the exchanges’ observation letter, approval of shareholders and creditors, and the NCLT’s sanction before it takes effect.

Shareholders on the register on the record date receive the new shares; the merging company’s shares stop trading shortly before it.

How mergers work, step by step →

Updated 19:38 IST · Information from public filings. Not investment advice.